SCHEMBL7418656

SCHEMBL7418656

CCC(=O)OCCC1CCNCC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.40
ITGB3 P05106 9/20 0.39
ITGA2B P08514 9/20 0.39
GNAI3 P08754 1/20 0.39
GNAO1 P09471 1/20 0.39
GNAI1 P63096 1/20 0.39
SLC6A1 P30531 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRB2 P47870 2/20 0.39
SLC6A12 P48065 2/20 0.39
SLC6A11 P48066 2/20 0.39
SLC6A13 Q9NSD5 2/20 0.39
GABRA1 P14867 1/20 0.39
GABRR1 P24046 1/20 0.39
GABRA4 P48169 1/20 0.39
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7418650 0.98 GNAO1 (0.41) NAAAITGB3ITGA2BGNAI3GNAO1
SCHEMBL6050125 0.90 NAAA (0.46) NAAAITGB3ITGA2BGNAI3GNAO1
SCHEMBL28085500 0.87 NAAA (0.47) NAAA
SCHEMBL27986982 0.86 GNAO1 (0.43) ITGB3ITGA2BGNAI3GNAO1GNAI1
SCHEMBL25022401 0.83 SMN1; SMN2 (0.46) NAAA
SCHEMBL3624797 0.81 SLC6A1 (0.41) ITGB3ITGA2BGNAI3GNAO1GNAI1
SCHEMBL3923983 0.81 LMNA (0.41) ITGB3ITGA2BSLC6A1GABRA5GABRB2
SCHEMBL16470982 0.81 SMN1; SMN2 (0.49) NAAA
SCHEMBL27627251 0.81 ITGB3 (0.39) ITGB3ITGA2BGNAI3GNAO1GNAI1
SCHEMBL9344097 0.81 GABRA5 (0.44) ITGB3ITGA2BGNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101365693-A Selected CGRP antagonists, method for the production thereof and use thereof as medicaments BOEHRINGER INGELHEIM INT (DE) 2009-02-11 CN disclosed
CN-101273021-A Selected CGRP antagonists, methods for the production thereof and their use as medicaments BOEHRINGER INGELHEIM INT (DE) 2008-09-24 CN disclosed
EP-0815103-A1 TRYPSIN AND THROMBIN INHIBITORS Novartis AG (CH) 1998-01-07 EP disclosed
WO-1996029327-A1 TRYPSIN AND THROMBIN INHIBITORS NOVARTIS AG (CH) 1996-09-26 WO disclosed